Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CreaVax-HCC Dendritic Cell Therapy in Hepatocellular Carcinoma Post-Resection/Locoregional Treatment (Phase I/IIa)
KCT0000427Phase 2Completed
- Sponsor
- Ministry of Health & Welfare
- Start
- Mar 2009
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CreaVax-HCC in hepatocellular carcinoma (HCC), sponsored by Ministry of Health & Welfare. Started Mar 2009; status: completed.
02
Drugs
CreaVax-HCC
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on KCT0000427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000427.